{"id":"sodium-valproate-treatment","safety":{"commonSideEffects":[{"rate":"25-50","effect":"Tremor"},{"rate":"20-30","effect":"Weight gain"},{"rate":"5-12","effect":"Alopecia (hair loss)"},{"rate":"1-5","effect":"Thrombocytopenia"},{"rate":"1-3","effect":"Hepatotoxicity"},{"rate":"<1","effect":"Pancreatitis"},{"rate":"10-20","effect":"Nausea and vomiting"},{"rate":"10-15","effect":"Sedation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sodium valproate increases GABA levels by inhibiting GABA catabolism and enhancing GABA synthesis, leading to increased inhibitory neurotransmission. Additionally, it acts as a histone deacetylase inhibitor, which affects gene expression and has been investigated for epigenetic effects in various conditions including cancer and neurological disorders.","oneSentence":"Sodium valproate inhibits histone deacetylase (HDAC) and enhances gamma-aminobutyric acid (GABA) neurotransmission in the central nervous system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:08:37.866Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Epilepsy and seizure disorders"},{"name":"Bipolar disorder"},{"name":"Migraine prophylaxis"},{"name":"Investigational use in certain malignancies (HDAC inhibition)"}]},"trialDetails":[{"nctId":"NCT07487675","phase":"PHASE2","title":"Evaluation of Intravenous Sodium Valproate on Interleukin-6 Levels in Patients With TMJ Disc Displacement","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tanta University","startDate":"2024-09-29","conditions":"Temporomandibular Joint Internal Derangement (ADWR)","enrollment":10},{"nctId":"NCT06929273","phase":"PHASE3","title":"A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-07-18","conditions":"Bipolar Disorder Type I With Mania","enrollment":450},{"nctId":"NCT06714448","phase":"","title":"A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2025-04-29","conditions":"Epilepsy, Seizures","enrollment":3500},{"nctId":"NCT07140913","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-10-08","conditions":"Mania, Bipolar Disorder","enrollment":424},{"nctId":"NCT05603104","phase":"PHASE3","title":"Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-04-27","conditions":"Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression","enrollment":1254},{"nctId":"NCT06433635","phase":"PHASE4","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-01","conditions":"Bipolar I Disorder, Depression","enrollment":2726},{"nctId":"NCT06081283","phase":"PHASE4","title":"Antiseizure Medication in Seizure Networks at Early Acute Brain Injury","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2023-11-20","conditions":"Brain Injuries, Acute, Brain Injuries, Traumatic, Brain Ischemia","enrollment":5},{"nctId":"NCT07226141","phase":"PHASE1, PHASE2","title":"Valproate for the Treatment of Residual Amblyopia","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-01-01","conditions":"Amblyopia, Amblyopia Unilateral, Amblyopia, Anisometropic","enrollment":28},{"nctId":"NCT01552434","phase":"PHASE1","title":"Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-03-16","conditions":"Advanced Malignant Neoplasm, Castleman Disease, Digestive System Carcinoma","enrollment":155},{"nctId":"NCT05973786","phase":"PHASE3","title":"The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-02-11","conditions":"Bipolar Depression","enrollment":418},{"nctId":"NCT07166393","phase":"PHASE2, PHASE3","title":"Valproic AcId for Traumatic BRAin INjury Trial","status":"NOT_YET_RECRUITING","sponsor":"Northwestern University","startDate":"2026-05","conditions":"Moderate Traumatic Brain Injury (TBI), Severe Traumatic Brain Injury","enrollment":432},{"nctId":"NCT05694936","phase":"PHASE2","title":"Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"Australasian Gastro-Intestinal Trials Group","startDate":"2023-01-23","conditions":"Metastatic Colorectal Cancer","enrollment":90},{"nctId":"NCT04274179","phase":"PHASE3","title":"Ketogenic Diet for New-Onset Absence Epilepsy","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2020-08-10","conditions":"Absence Epilepsy, Ketogenic Dieting, Epilepsy, Absence","enrollment":40},{"nctId":"NCT05756621","phase":"","title":"Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest","status":"RECRUITING","sponsor":"University of Milano Bicocca","startDate":"2022-01-15","conditions":"Status Epilepticus, Cardiac Arrest","enrollment":80},{"nctId":"NCT07046676","phase":"PHASE4","title":"Pharmacogenetics-Based Study on Individualized Use of Sodium Valproate","status":"RECRUITING","sponsor":"The First Affiliated Hospital of University of South China","startDate":"2022-12-01","conditions":"Epilepsy","enrollment":312},{"nctId":"NCT03689114","phase":"PHASE4","title":"Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2021-05-10","conditions":"Epilepsies, Partial","enrollment":58},{"nctId":"NCT07024303","phase":"EARLY_PHASE1","title":"Measurement of Treatment Effects","status":"NOT_YET_RECRUITING","sponsor":"Matthew J O'Brien, PhD, BCBA-D","startDate":"2025-06-15","conditions":"Challenging Behavior, Autism Spectrum Disorder","enrollment":20},{"nctId":"NCT02446652","phase":"PHASE3","title":"Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer","status":"WITHDRAWN","sponsor":"National Institute of Cancerología","startDate":"2015-01-01","conditions":"Cervical Cancer","enrollment":""},{"nctId":"NCT06549426","phase":"NA","title":"Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation-2 (TELSTAR-2)","status":"RECRUITING","sponsor":"University of Twente","startDate":"2025-04-10","conditions":"Coma, Electrographic Status Epilepticus","enrollment":150},{"nctId":"NCT03671681","phase":"PHASE4","title":"Mindfulness Therapy for Chronic Migraine","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2018-11-05","conditions":"Chronic Migraine, Medication Overuse Headache","enrollment":177},{"nctId":"NCT02473250","phase":"PHASE4","title":"Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2015-01","conditions":"Bipolar Disorder","enrollment":40},{"nctId":"NCT05263674","phase":"PHASE3","title":"Fast Acute Sedation at Intensive Care vs. High-dose i.v. Anti-seizure Medication for Treatment of Non-convulsive Status Epilepticus (FAST-trial)","status":"RECRUITING","sponsor":"University of Southern Denmark","startDate":"2022-02-07","conditions":"Non-Convulsive Status Epilepticus","enrollment":140},{"nctId":"NCT05722951","phase":"PHASE3","title":"Metformin Efficacy and Safety in Epileptic Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-18","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT00581009","phase":"PHASE1, PHASE2","title":"The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2001-05-30","conditions":"Major Depressive Disorder, Bipolar Disorder","enrollment":49},{"nctId":"NCT05224531","phase":"PHASE2","title":"Effect of CS1 in Subjects With Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Cereno Scientific AB","startDate":"2022-05-05","conditions":"Pulmonary Arterial Hypertension","enrollment":25},{"nctId":"NCT04218981","phase":"NA","title":"Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders","status":"COMPLETED","sponsor":"Central South University","startDate":"2020-01-15","conditions":"Common Mental Disorder","enrollment":200},{"nctId":"NCT03717909","phase":"PHASE2","title":"Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Birmingham","startDate":"2018-12-28","conditions":"Wolfram Syndrome","enrollment":63},{"nctId":"NCT01817751","phase":"PHASE2","title":"Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2013-04-11","conditions":"Glioblastoma, Recurrent Adult Brain Neoplasm, Malignant Glioma","enrollment":47},{"nctId":"NCT06248931","phase":"PHASE3","title":"Valproate Versus Topiramate in Migraine","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2022-05-01","conditions":"Migraine Disorders","enrollment":600},{"nctId":"NCT06485726","phase":"PHASE4","title":"Valproate Versus Propranolol in Migraine","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2023-01-23","conditions":"Migraine Disorders","enrollment":600},{"nctId":"NCT00145470","phase":"PHASE3","title":"12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-06-02","conditions":"Bipolar Disorder","enrollment":326},{"nctId":"NCT04698525","phase":"PHASE3","title":"Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.","status":"COMPLETED","sponsor":"Universidad Autonoma de San Luis Potosí","startDate":"2019-02-15","conditions":"Migraine Headache","enrollment":33},{"nctId":"NCT06393309","phase":"","title":"Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2022-09-03","conditions":"Treatment of Idiopathic Generalized Epilepsy","enrollment":169},{"nctId":"NCT02265770","phase":"PHASE2, PHASE3","title":"An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma","status":"RECRUITING","sponsor":"Centre Leon Berard","startDate":"2015-06-02","conditions":"Childhood Ependymoma","enrollment":536},{"nctId":"NCT02893371","phase":"","title":"Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2016-09","conditions":"Bipolar Disorder","enrollment":1037352},{"nctId":"NCT06020898","phase":"PHASE2","title":"Sodium Valproate in Patients With Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2023-09-01","conditions":"Acute Ischemic Stroke","enrollment":40},{"nctId":"NCT00221429","phase":"PHASE3","title":"Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2001-03","conditions":"Bipolar Disorder","enrollment":153},{"nctId":"NCT06211283","phase":"PHASE1","title":"Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects.","status":"COMPLETED","sponsor":"Desitin Arzneimittel GmbH","startDate":"2023-09-11","conditions":"Food-drug Interaction","enrollment":28},{"nctId":"NCT04940572","phase":"PHASE2","title":"Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome","status":"UNKNOWN","sponsor":"Centre d'Etude des Cellules Souches","startDate":"2021-11-26","conditions":"Wolfram Syndrome","enrollment":23},{"nctId":"NCT03825250","phase":"PHASE1, PHASE2","title":"The Val-CARD Trial","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2018-11-06","conditions":"Cardiac Valve Disease, Coronary Artery Disease, Organ Failure, Multiple","enrollment":122},{"nctId":"NCT06089356","phase":"PHASE4","title":"Zolmitriptane as Prophylaxis for Chilhood Migraine","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2023-01-01","conditions":"Migraine","enrollment":90},{"nctId":"NCT05481957","phase":"PHASE4","title":"Vortioxetine Adjunctive Treatment in Bipolar Depression","status":"COMPLETED","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2022-03-01","conditions":"Bipolar Depression","enrollment":131},{"nctId":"NCT05017454","phase":"EARLY_PHASE1","title":"Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2021-05-01","conditions":"Alopecia Areata","enrollment":67},{"nctId":"NCT02600507","phase":"PHASE3","title":"Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression","status":"COMPLETED","sponsor":"Intra-Cellular Therapies, Inc.","startDate":"2016-03-07","conditions":"Bipolar Depression","enrollment":529},{"nctId":"NCT00261443","phase":"PHASE4","title":"A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2005-09","conditions":"Bipolar Disorder","enrollment":1270},{"nctId":"NCT04513314","phase":"PHASE4","title":"Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium","status":"WITHDRAWN","sponsor":"University of Miami","startDate":"2023-03-28","conditions":"Covid19, Hyperactive Delirium, Pneumonia, Viral","enrollment":""},{"nctId":"NCT05697614","phase":"PHASE4","title":"The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children","status":"UNKNOWN","sponsor":"Dr Cipto Mangunkusumo General Hospital","startDate":"2023-03-01","conditions":"Drug Resistant Epilepsy","enrollment":100},{"nctId":"NCT02607904","phase":"PHASE2","title":"An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2016-12-15","conditions":"Epilepsy","enrollment":30},{"nctId":"NCT03616223","phase":"PHASE1, PHASE2","title":"FX-322 in Sensorineural Hearing Loss","status":"COMPLETED","sponsor":"Frequency Therapeutics","startDate":"2018-07-03","conditions":"Sensorineural Hearing Loss","enrollment":23},{"nctId":"NCT03652974","phase":"PHASE4","title":"Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2018-09-06","conditions":"Schizophrenia","enrollment":145},{"nctId":"NCT03636958","phase":"NA","title":"Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy","status":"WITHDRAWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2021-02-15","conditions":"Refractory Epilepsy","enrollment":""},{"nctId":"NCT01730313","phase":"PHASE2","title":"Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda - 2012","status":"WITHDRAWN","sponsor":"Centers for Disease Control and Prevention","startDate":"2016-02","conditions":"Nodding Syndrome","enrollment":""},{"nctId":"NCT03681158","phase":"PHASE1","title":"Study of Excretion Balance and Pharmacokinetics of [14C]-Sodium Valproate (3.7 MBq) in Healthy Postmenopausal or Permanently Sterile Female Subjects","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-10-05","conditions":"Epilepsy","enrollment":5},{"nctId":"NCT00484471","phase":"PHASE4","title":"ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness","status":"COMPLETED","sponsor":"Korea Otsuka International Asia Arab","startDate":"2007-10","conditions":"Bipolar Disorder","enrollment":127},{"nctId":"NCT00159588","phase":"NA","title":"Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?","status":"COMPLETED","sponsor":"Norwegian University of Science and Technology","startDate":"2004-01","conditions":"Headache","enrollment":64},{"nctId":"NCT02056236","phase":"NA","title":"TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation","status":"COMPLETED","sponsor":"University of Twente","startDate":"2014-04","conditions":"Cardiac Arrest, Anoxic Encephalopathy, Status Epilepticus","enrollment":172},{"nctId":"NCT03940326","phase":"PHASE4","title":"Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2018-04-01","conditions":"Epilepsy, Idiopathic Generalized","enrollment":103},{"nctId":"NCT00145509","phase":"PHASE3","title":"40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-08","conditions":"Bipolar Disorder","enrollment":77},{"nctId":"NCT04531592","phase":"PHASE2","title":"Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients","status":"WITHDRAWN","sponsor":"Westat","startDate":"2022-01","conditions":"Acute Kidney Injury, Ischemia Reperfusion Injury","enrollment":""},{"nctId":"NCT04531579","phase":"PHASE2","title":"Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma Patients","status":"WITHDRAWN","sponsor":"Westat","startDate":"2022-01","conditions":"Acute Kidney Injury, Ischemia Reperfusion Injury","enrollment":""},{"nctId":"NCT00879437","phase":"PHASE2","title":"Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2009-09-01","conditions":"Glial Cell Tumors, Malignant Gliomas, Glioblastoma Multiforme","enrollment":38},{"nctId":"NCT00483548","phase":"PHASE3","title":"Adjunctive Ziprasidone in the Treatment of Bipolar I Depression","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-10","conditions":"Bipolar Disorder, Depression, Bipolar","enrollment":298},{"nctId":"NCT00221403","phase":"PHASE3","title":"Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2004-09","conditions":"Bipolar Disorder","enrollment":46},{"nctId":"NCT03490487","phase":"PHASE4","title":"Electroclinical Effect of Steroid in Patients With Benign Childhood Epilepsy With Centrotemporal Spikes","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-06-20","conditions":"Benign Childhood Epilepsy With Centrotemporal Spikes","enrollment":100},{"nctId":"NCT03204500","phase":"PHASE2","title":"Dual Treatment With Lithium and Valproate in ALS.","status":"COMPLETED","sponsor":"El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez","startDate":"2016-05","conditions":"Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis, Sporadic","enrollment":43},{"nctId":"NCT04482764","phase":"PHASE1","title":"Valproic Acid in Treating Cyanotic Breath Holding Spells","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-01-30","conditions":"Breathhold","enrollment":150},{"nctId":"NCT00579280","phase":"PHASE4","title":"Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2007-07","conditions":"Bipolar Disorder, Panic Disorder, Generalized Anxiety Disorder","enrollment":224},{"nctId":"NCT01272531","phase":"","title":"Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2011-04","conditions":"Bipolar Affective Disorder","enrollment":560},{"nctId":"NCT04191863","phase":"","title":"Sleep Architecture in Valproate-induced Nocturnal Enuresis in Primary School and Preschool Children.","status":"COMPLETED","sponsor":"Mansoura University Hospital","startDate":"2018-09-01","conditions":"Epilepsy, Nocturnal Enuresis","enrollment":260},{"nctId":"NCT02707965","phase":"PHASE1","title":"Characterization of Epilepsy Patients BEEP 2b","status":"COMPLETED","sponsor":"Food and Drug Administration (FDA)","startDate":"2017-06-08","conditions":"Epilepsy","enrollment":21},{"nctId":"NCT00167934","phase":"NA","title":"Determining Metabolic Effects of Valproate and Antipsychotic Therapy","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2004-12","conditions":"Schizophrenia","enrollment":164},{"nctId":"NCT04262999","phase":"","title":"Bone Mineral Density and Periodontal Status in Patients on Antiepileptic Drug","status":"UNKNOWN","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2020-01-01","conditions":"Alveolar Bone Loss","enrollment":140},{"nctId":"NCT01760785","phase":"NA","title":"Valproate for Mood Swings and Alcohol Use Following Head Injury","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2008-09","conditions":"Traumatic Brain Injury (TBI), Alcoholism","enrollment":50},{"nctId":"NCT02343575","phase":"PHASE4","title":"Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU","status":"TERMINATED","sponsor":"Stanford University","startDate":"2015-01","conditions":"Hyperactive Delirium, Mixed Delirium","enrollment":3},{"nctId":"NCT03953781","phase":"","title":"Effect of Valproate Versus Levetiracetam Monotherapy on Reproductive Functions in Epileptic Males","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2016-06-01","conditions":"Epilepsy","enrollment":50},{"nctId":"NCT03914534","phase":"PHASE4","title":"Bioequivalence Study of Sodium Divalproate Tablets 500 mg","status":"COMPLETED","sponsor":"Tecnoquimicas","startDate":"2017-04-17","conditions":"Healthy","enrollment":30},{"nctId":"NCT03903302","phase":"PHASE1","title":"Study Investigation Pharmacokinetics and Pharmacodynamics of CS1","status":"COMPLETED","sponsor":"Cereno Scientific AB","startDate":"2017-10-06","conditions":"Thrombosis","enrollment":30},{"nctId":"NCT02926976","phase":"NA","title":"The Optimal Treatment for Treatment-resistant Schizophrenia","status":"UNKNOWN","sponsor":"Shanghai Mental Health Center","startDate":"2016-11","conditions":"Schizophrenia","enrollment":150},{"nctId":"NCT01791868","phase":"NA","title":"Efficacy Study of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-02","conditions":"Generalized Convulsive Status Epilepticus, Intensive Care Unit","enrollment":245},{"nctId":"NCT00254488","phase":"PHASE4","title":"Treatment of Bipolar Mania in Older Adults","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2005-11","conditions":"Bipolar Disorder, Mania","enrollment":224},{"nctId":"NCT00552500","phase":"NA","title":"Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2003-02","conditions":"Insulin Resistance, Body Composition","enrollment":120},{"nctId":"NCT01182285","phase":"PHASE2","title":"A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-09-24","conditions":"Thyroid Neoplasm","enrollment":13},{"nctId":"NCT01622439","phase":"PHASE1, PHASE2","title":"Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma","status":"COMPLETED","sponsor":"Lund University Hospital","startDate":"2012-06","conditions":"Diffuse Large B-cell Lymphoma","enrollment":50},{"nctId":"NCT02011750","phase":"PHASE4","title":"Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2013-04-01","conditions":"Toxoplasmosis, Schizophrenia","enrollment":109},{"nctId":"NCT02625779","phase":"PHASE2","title":"Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression","status":"WITHDRAWN","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2016-03-01","conditions":"Depression, Bipolar","enrollment":""},{"nctId":"NCT01543139","phase":"PHASE2","title":"Cytidine- and Creatine-Containing Drug in Treating Bipolar Depression","status":"WITHDRAWN","sponsor":"Ewha Womans University","startDate":"2015-12-01","conditions":"Bipolar Depression","enrollment":""},{"nctId":"NCT03112889","phase":"PHASE2","title":"Sodium Valproate for GSDV","status":"COMPLETED","sponsor":"University College, London","startDate":"2015-01","conditions":"Glycogen Storage Disease Type V, McArdle Disease","enrollment":8},{"nctId":"NCT00318929","phase":"NA","title":"Tolerability and Efficacy of Depakote-extended Release in the Elderly","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2006-04","conditions":"Elderly, Epilepsy, Seizures","enrollment":14},{"nctId":"NCT00000439","phase":"PHASE2","title":"Drug Treatment for Alcoholics With Bipolar Disorder","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2000-10","conditions":"Alcoholism, Bipolar Disorder","enrollment":72},{"nctId":"NCT02100644","phase":"PHASE4","title":"Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-04-12","conditions":"Epilepsy","enrollment":33},{"nctId":"NCT02727101","phase":"PHASE4","title":"Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.","status":"TERMINATED","sponsor":"Mid-Atlantic Epilepsy and Sleep Center, LLC","startDate":"2015-11","conditions":"Epilepsy","enrollment":8},{"nctId":"NCT03235531","phase":"PHASE4","title":"Assessment of Valproate on Ethanol Withdrawal","status":"UNKNOWN","sponsor":"CAMC Health System","startDate":"2017-07-11","conditions":"Alcohol Dependence, Alcohol Withdrawal Syndrome, Trauma","enrollment":210},{"nctId":"NCT02593643","phase":"EARLY_PHASE1","title":"Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2016-01","conditions":"Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder","enrollment":9},{"nctId":"NCT03039842","phase":"PHASE3","title":"Combination of Dextromethorphan and Memantine in Treating Bipolar Disorder","status":"UNKNOWN","sponsor":"National Cheng-Kung University Hospital","startDate":"2013-01-01","conditions":"Bipolar Disorder II","enrollment":300},{"nctId":"NCT02648633","phase":"PHASE1","title":"Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma","status":"TERMINATED","sponsor":"University of Virginia","startDate":"2016-05-24","conditions":"Glioblastoma","enrollment":4},{"nctId":"NCT01463111","phase":"NA","title":"Decision-Making in Bipolar Disorder","status":"COMPLETED","sponsor":"Emory University","startDate":"2011-05","conditions":"Bipolar Disorder","enrollment":37},{"nctId":"NCT02205931","phase":"PHASE4","title":"Ketogenic Diet in Infants With Epilepsy (KIWE)","status":"UNKNOWN","sponsor":"University College, London","startDate":"2015-01","conditions":"Epilepsy","enrollment":160},{"nctId":"NCT00203385","phase":"PHASE4","title":"Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder","status":"TERMINATED","sponsor":"Tuscaloosa Research & Education Advancement Corporation","startDate":"2003-05","conditions":"PTSD","enrollment":20},{"nctId":"NCT01784666","phase":"PHASE2","title":"Adjunctive Isradipine for the Treatment of Bipolar Depression","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2013-02","conditions":"Bipolar Disorder","enrollment":2},{"nctId":"NCT00913848","phase":"PHASE1","title":"To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions","status":"COMPLETED","sponsor":"Sandoz","startDate":"2005-10","conditions":"Epilepsy, Bipolar Disorder","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":73,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Depakote"],"phase":"marketed","status":"active","brandName":"Sodium Valproate treatment","genericName":"Sodium Valproate treatment","companyName":"University of Pittsburgh","companyId":"university-of-pittsburgh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sodium valproate inhibits histone deacetylase (HDAC) and enhances gamma-aminobutyric acid (GABA) neurotransmission in the central nervous system. Used for Epilepsy and seizure disorders, Bipolar disorder, Migraine prophylaxis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}